Holen Sie sich die Stockscreener-App
0.29
1.29%
-0.0038
Handel nachbörslich:
.29
Schlusskurs vom Vortag:
$0.2938
Offen:
$0.3098
24-Stunden-Volumen:
5.21M
Relative Volume:
1.53
Marktkapitalisierung:
$13.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.26M
KGV:
-0.2455
EPS:
-1.1814
Netto-Cashflow:
$-13.50M
1W Leistung:
+6.34%
1M Leistung:
-12.91%
6M Leistung:
-86.64%
1J Leistung:
-93.12%
1-Tages-Spanne:
$0.2802
$0.32
1-Wochen-Bereich:
$0.2453
$0.32
52-Wochen-Spanne:
$0.1853
$4.43
Intensity Therapeutics Inc Stock (INTS) Company Profile
Firmenname
Intensity Therapeutics Inc
Sektor
Branche
Telefon
203-221-7381
Adresse
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Vergleichen Sie INTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.29 | 13.83M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Intensity Therapeutics Inc Aktie (INTS) Neueste Nachrichten
Intensity Therapeutics Inc (INTS) Stock: Navigating a Year of Volatility - investchronicle.com
Shelton-based biotech regains Nasdaq compliance - Hartford Business Journal
Is now a turning point for Intensity Therapeutics Inc.July 2025 Action & Free Growth Oriented Trading Recommendations - Newser
Analyzing recovery setups for Intensity Therapeutics Inc. investors [Weekly Gains Report]Free Safe Capital Growth Stock Tips - Newser
Analyzing recovery setups for Intensity Therapeutics Inc. investorsHigh Accuracy Trade Setup Identification - Newser
Intensity (INTS) Q2 Net Loss Drops 50% - AOL.com
Intensity Therapeutics Amends Bylaws for Quorum Change - MSN
Sentiment analysis tools applied to Intensity Therapeutics Inc.Free Triple Digit Return Stock Predictions - Newser
Can momentum traders help lift Intensity Therapeutics Inc.New Guidance & Real-Time Market Trend Scan - Newser
How to recover losses in Intensity Therapeutics Inc. stock [2025 Pullback Review]Free Community Trade Idea Sharing Platform - Newser
Brookline Capital upgrades Intensity Therapeutics stock rating to Buy By Investing.com - Investing.com Australia
Using data filters to optimize entry into Intensity Therapeutics Inc.Value Investing Summary and Earnings Outlook - Newser
Intensity Therapeutics regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Nigeria
Intensity Therapeutics regains compliance with Nasdaq listing requirements - Investing.com
Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - WV News
How Intensity Therapeutics Inc. stock performs during market volatilityFree Stock Market Watch With Alerts - Newser
Using Python tools to backtest Intensity Therapeutics Inc. strategiesSwing Trade Entry and Exit Point Analysis - Newser
Why Intensity Therapeutics Inc. stock attracts strong analyst attentionBuy and Hold Position Summary Review - Newser
Multi factor analysis applied to Intensity Therapeutics Inc.Intraday Movement Recap and Chart Summary - Newser
Is Intensity Therapeutics Inc. still worth holding after the dipStock Portfolio Risk and Return Analysis - Newser
Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Morningstar
Is Intensity Therapeutics Inc. meeting your algorithmic filter criteriaTechnical Insight Guide for Safer Trades - Newser
Shelton biotech raises millions for novel cancer treatment - Hartford Business Journal
How to recover losses in Intensity Therapeutics Inc. stockLow Risk Strategy with Smart Entry Zones - Newser
why intensity therapeutics inc. stock attracts strong analyst attentionAI-Based Reversal Point Prediction Signal - Newser
Intensity Therapeutics Raises $6.6 Million in July Offering - TipRanks
Intensity Therapeutics Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - investchronicle.com
Intensity Therapeutics raises $6.6M from ATM stock sales in July - TipRanks
Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025 - Citizen Tribune
Biotech Intensity Therapeutics Secures $6.6M Funding at Premium Price, Extends Operations Through 2026 - Stock Titan
Intensity Therapeutics Inc.’s Beta Climbs After Market VolatilityChart Driven High Reward Trading Setup Presented - beatles.ru
Is Intensity Therapeutics Inc. stock overvalued or undervaluedBuild wealth faster with consistent investment plans - Jammu Links News
What analysts say about Intensity Therapeutics Inc. stockUnlock superior stock analysis tools - Jammu Links News
What are analysts’ price targets for Intensity Therapeutics Inc. in the next 12 monthsFree Trading Psychology Coaching - Jammu Links News
Is Intensity Therapeutics Inc. a good long term investmentFree Stock Selection - Jammu Links News
How does Intensity Therapeutics Inc. generate profit in a changing economyMaximize your returns with expert insights - Jammu Links News
Is it the right time to buy Intensity Therapeutics Inc. stockTremendous growth opportunities - Jammu Links News
How strong is Intensity Therapeutics Inc. company’s balance sheetMaximize your returns with portfolio optimization - Jammu Links News
What catalysts could drive Intensity Therapeutics Inc. stock higher in 2025Consistent high-yield stocks - Jammu Links News
What drives Intensity Therapeutics Inc. stock priceRobust investment performance - Jammu Links News
How does Intensity Therapeutics Inc. compare to its industry peersDiscover dynamic stocks ready to soar - Jammu Links News
Finanzdaten der Intensity Therapeutics Inc-Aktie (INTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):